Safety and immunogenicity of a live attenuated RSV vaccine in healthy RSV-seronegative children 5 to 24 months of age.

Elissa Malkin*, Ram Yogev, Nazha Abughali, Joseph Sliman, C. Kathy Wang, Fengrong Zuo, Chin Fen Yang, Mark Eickhoff, Mark T. Esser, Roderick S. Tang, Filip Dubovsky

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

67 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and immunogenicity of a live attenuated RSV vaccine in healthy RSV-seronegative children 5 to 24 months of age.'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology